Virtual Care Optimization for COPD Management
(VC-OPTIONS Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on virtual care services for managing COPD, so it's likely you can continue your current treatment, but you should confirm with the trial organizers.
What data supports the effectiveness of the treatment VC-OPTIONS for COPD management?
The research suggests that using virtual care, like remote monitoring and telemedicine, can help manage COPD by potentially reducing hospital stays and improving care quality. Engaging healthcare providers with online tools and feedback has shown to improve care delivery and reduce costs, which may support the effectiveness of VC-OPTIONS.12345
How does the Virtual Care Optimization treatment for COPD differ from other treatments?
The Virtual Care Optimization treatment for COPD is unique because it uses telemedicine to provide care remotely, including virtual consultations, telemonitoring, and home-based rehabilitation. This approach allows for continuous monitoring and personalized care without the need for frequent hospital visits, potentially reducing healthcare costs and improving patient engagement.34678
What is the purpose of this trial?
VA is a leader in virtual care (VC), including the patient portal, mobile apps, and telehealth programs. VC has great utility for managing chronic conditions like chronic obstructive pulmonary disease (COPD). However, adoption of many VC services has been slow. Lack of awareness about these services is one of the most prominent patient- and healthcare team-facing barriers to adopting VC. This study will develop, refine, and pilot a stakeholder-informed multicomponent implementation strategy to support adoption of VC, referred to as VC-OPTIONS (Virtual Care for Chronic Obstructive Pulmonary Disease Adoption Support). This feasibility trial will pilot the VC-OPTIONS implementation strategy to assess feasibility and acceptability and gather preliminary effectiveness data to inform a larger hybrid effectiveness-implementation trial. The core component of VC-OPTIONS will be the provision of information via VA's Annie texting program to empower patients with knowledge about the array of VC services and how they can be used to support COPD management. It is hypothesized that this strategy will be acceptable and feasible. This work will improve patient and team awareness of and communication about VC services, and support patient access to VC services for COPD management.
Research Team
Stephanie Robinson, PhD
Principal Investigator
VA Bedford HealthCare System, Bedford, MA
Eligibility Criteria
This trial is for US Veterans who are users of the Veterans Health Administration (VHA), have been diagnosed with COPD, can communicate in English, and own a text-enabled phone. It's not open to those who've already taken part in research preparing for this intervention.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive educational content about virtual care for COPD via Annie text messaging
Follow-up
Participants are monitored for changes in awareness and intention to adopt virtual care services
Treatment Details
Interventions
- VC-OPTIONS
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor